• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material
04 Mar
Annnouncements

VAXIL BIO PROPOSED REVERSE TAKEOVER WITH COPPER BULLET TERMINATED AND UPDATE OF RESEARCH ACTIVITIES

… Read the rest
Posted on March 4, 2024March 7, 2024 by Gadi Levin
10 Jan
Annnouncements

VAXIL BIO ENTERS INTO LETTER OF INTENT WITH COPPER BULLET MINES IN RESPECT OF A PROPOSED REVERSE TAKEOVER

… Read the rest
Posted on January 10, 2024January 11, 2024 by Gadi Levin
02 Aug
Annnouncements

VAXIL PROVIDES UPDATE ON RESEARCH ACTIVITIES AND MANAGEMENT CHANGES

… Read the rest
Posted on August 2, 2023January 11, 2024 by Gadi Levin
07 Mar
Annnouncements

VAXIL PROVIDES UPDATE ON RESEARCH ACTIVITIES

… Read the rest
Posted on March 7, 2022March 7, 2022 by Gadi Levin
08 Feb
Annnouncements

VAXIL’S ANNUAL AND SPECIAL SHAREHOLDERS MEETING

… Read the rest
Posted on February 8, 2022February 16, 2022 by Gadi Levin
Older posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2025 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material
  • Vaxil Locations
  • Contact Us
  • Subscribe